Massive Hepatic Necrosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.
|
29246445 |
2018 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.
|
29246445 |
2018 |
Liver Failure, Acute
|
0.300 |
Biomarker
|
disease |
CTD_human |
Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.
|
29246445 |
2018 |
Drug-Induced Liver Disease
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.
|
29246445 |
2018 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.
|
29246445 |
2018 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.
|
29246445 |
2018 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.
|
29246445 |
2018 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease.
|
29246445 |
2018 |
Autosomal Recessive Polycystic Kidney Disease
|
0.200 |
Biomarker
|
disease |
RGD |
Knockout of
|
31630543 |
2019 |
Hypothyroidism
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Alanine aminotransferase measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
Serum Alanine Aminotransferase Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
Female infertility
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Seizures
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
We here show that targeted deletion of Panx1 in astrocytes or neurons has opposing effects on acute seizures induced by kainic acid.
|
30862176 |
2020 |
Seizures
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Pannexin-1 (Panx1) expression is raised in several animal seizure models and in resected human epileptic brain tissue, suggesting relevance to epilepsy.
|
28886985 |
2019 |
Seizures
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
Although there are only few studies implicating Panx1 in seizures, they are illustrative of the dual role that Panx1 has on neuronal excitability.
|
28284836 |
2019 |
Seizures
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Importantly, the protein levels of Panx1 positively correlated with the frequency of seizures.
|
28036289 |
2017 |
Seizures
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Finally there is recent evidence for Cx43 hemichannels and Panx1 channels in glial membranes which could play a role in brain damage and seizure activity.
|
22796594 |
2012 |
Neoplasm Metastasis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
The effects of Panx1 on HCC cell metastasis and invasion were observed by transwell.
|
31737105 |
2019 |
Tumor Cell Invasion
|
0.040 |
AlteredExpression
|
phenotype |
BEFREE |
Overexpression of Panx1 promoted invasion and migration of HCC cells through modulation of EMT in vitro and in vivo.
|
31737105 |
2019 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Overall, increased Panx-1 promotes migration and invasion in testicular cancer cells, and the effect is probably be related with ERK1/2 kinase activity.
|
31202174 |
2019 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Our results indicate that opening of Panx1 channels are required for <i>T. cruzi</i> invasion in cardiac myocytes, and we propose that targeting Panx1 channel could provide new potential therapeutic approaches to treat Chagas disease.
|
29141748 |
2018 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Here we show, using primary human dermal lymphatic endothelial cells (HDLECs), pharmacological tools (probenecid, Brilliant Blue FCF, mimetic peptides [<sup>10</sup>Panx]) and siRNA-mediated knockdown that Pannexin-1 is necessary for capillary tube formation on Matrigel and for VEGF-C-induced invasion.
|
29882918 |
2018 |
Neoplasm Metastasis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Pannexin 1 (PANX1) subunits form oligomeric plasma membrane channels that mediate nucleotide release for purinergic signalling, which is involved in diverse physiological processes such as apoptosis, inflammation, blood pressure regulation, and cancer progression and metastasis.
|
28134257 |
2017 |